Pharmaceutical firms brace for specter of massive drug price cuts

Published: 2011-11-15 07:00:00

Updated: 2011-11-15 07:00:00

Domestic drug firms are scrambling to slash their administrative and promotional expenses from the current 40 percent to 30 percent, as they are expected to face serious financial losses starting next year with the specter of the specter of the government’s defoaming price plan looming larger and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK